Search clinical trials for: Unsuspected Venous Thromboembolism

Total 3934 results

University of Calgary
Canadian Institutes of Health Research (CIHR); Canadian Venous Thromboembolism...

Completed

Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity (PARTUM)

Aspirin | Venous Thromboembolism | Postpartum Period

Canada, France, Ireland, Netherlands
Methodist Health System

Enrolling by invitation

Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma

Thromboembolism, Venous

United States
Centre Hospitalier Universitaire de Nīmes

Completed

Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in Women (WAST-VTE)

Venous Thrombosis

France
Momentum Data
Pfizer

Completed

The Incidence of Venous Thromboembolism in Atopic Dermatitis

Allergic Rhinitis | Deep Vein Thrombosis | Venous Thromboembolism | Atopic Dermatitis | Pulmonary Embolism | Food Allergy | Allergy to House Dust Mite | Allergy to Animal Dander | Cows Milk Allergy

United Kingdom
Assistance Publique Hopitaux De Marseille

Completed

Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole Genome

Venous Thromboembolism

France
Portola Pharmaceuticals

Completed

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) (APEX)

Venous Thromboembolism (VTE)

Belgium, Israel, Italy, United States, France, Bulgaria, Australia, Germany, Russian Federation, Hungary, Singapore, Austria, Chile, Canada, United Kingdom, Czechia, Poland, Spain, Romania, Latvia, South Africa, Croatia, Serbia, Peru, U... and more
Central Hospital, Nancy, France
Ministry of Health, France; University Hospital of Saint-Etienne; Grand Est Region

Completed

Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 (COVI-DOSE)

Thrombosis | Deep Vein Thrombosis | COVID | Pulmonary Embolism

France
Portola Pharmaceuticals

Completed

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)

Thromboembolism

Canada
Assistance Publique Hopitaux De Marseille

Completed

Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis (MARTHARecidive)

Venous Thromboembolism (VTE)

France
Pfizer

Completed

Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea

Venous Thromboembolism

Korea, Republic of
Ottawa Hospital Research Institute
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)... and other collaborators

Active, not recruiting

Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients (AIRPORT-MPN)

Primary Myelofibrosis | Venous Thromboembolism (VTE) | Polycythemia Vera (PV) | Essential Thrombocythemia (ET) | JAK2 Mutation | Myeloproliferative Neoplasm (MPN)

Canada
Brigham and Women's Hospital

Completed

Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism

United States
Brigham and Women's Hospital

Completed

Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism

United States
Brigham and Women's Hospital

Completed

Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism

United States
Brigham and Women's Hospital

Completed

Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism | Pulmonary Embolism | DVT

United States
Hospices Civils de Lyon

Completed

Complications Related to Vascular Access Devices in Home Parenteral Nutrition Patients (CRVADHPNP)

Vascular Access Complication

France
Centre Hospitalier Universitaire, Amiens

Completed

Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians (Observ-MTEV)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Survey | Anticoagulant

France
Medical University of Vienna

Completed

Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction Model

Venous Thromboembolism

Austria
Rijnstate Hospital

Completed

Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients (NADRO)

Critical Illness | Venous Thromboembolism | Therapeutic Drug Monitoring

Netherlands
Catalina Codreanu

Completed

Thrombosis in Patients With Multiple Myeloma in an University Medical Center (THRIMM)

Multiple Myeloma | Venous Thromboembolism | Arterial Thromboembolism

Netherlands
University of Texas Southwestern Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Thrombosis Outcomes in Pediatric Venous Thromboembolism (TOP)

Venous Thromboembolism

United States
Marc Blondon

Completed

Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study (PREFER-PP)

Pregnancy Related | Venous Thromboembolism

France, Switzerland
Centre Hospitalier Universitaire de Nīmes

Completed

Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism (CHIPS)

Venous Thromboembolism

France
University Hospital, Brest

Completed

Haemorrhages and Thromboembolic Venous Disease of the Postpartum (HEMOTHEPP)

Venous Thromboembolism | Postpartum Hemorrhage

France
Gruppo Oncologico Italiano di Ricerca Clinica

Completed

Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy (EDOI)

Cancer | Thromboembolism

Italy
Sanofi

Active, not recruiting

A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

Venous Thromboembolism

United States
University Hospital, Geneva

Completed

Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial (PP-HEP)

Venous Thromboembolism

Switzerland
Sanofi

Active, not recruiting

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

Venous Thromboembolism

United States
University of Utah

Completed

Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
CHAD

Terminated

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register) (START-Portugal)

Atrial Fibrillation | Venous Thromboembolism | Heart Valve Diseases or Prosthesis

Portugal
Tampere University Hospital
Heart Hospital, Tampere University Hospital

Completed

: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

Venous Thromboembolism | Pulmonary Embolism | Thromboprophylaxis

Finland
McMaster University
St. Joseph's Healthcare Hamilton; Hamilton Health Sciences Corporation

Completed

Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry (PAUSE-ER)

Atrial Fibrillation | Venous Thromboembolism | Arterial Vascular Disease

Canada
Denver Health and Hospital Authority

Terminated

STAT-STatin and Aspirin in Trauma (STAT)

Wounds and Injuries | Venous Thromboembolism

United States
The University of Texas Medical Branch, Galveston

Withdrawn

The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients

Colorectal Cancer | Crohn Disease | Deep Vein Thrombosis | Ulcerative Colitis | Diverticular Diseases | Venous Thromboses
Daiichi Sankyo, Inc.

Completed

Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism

Pulmonary Embolism | Thrombotic Disease

Netherlands, Spain, United States, France, Austria, Belgium, Germany, Italy
Montefiore Medical Center
The Plastic Surgery Foundation

Completed

Use of Tranexamic Acid in Reduction Mammoplasty (TREX-ARM)

Venous Thromboembolism | Hematoma Postoperative

United States
Nottingham University Hospitals NHS Trust

Active, not recruiting

Sonoclot to Evaluate Thrombotic Risk in Proteinuric Pregnancy

Chronic Kidney Diseases | Pregnancy Complications | Venous Thromboembolism | Proteinuria in Pregnancy

United Kingdom
Bayer
Janssen Research & Development, LLC

Completed

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

Treatment of Venous Thromboembolism in Cancer Patients

United Kingdom
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Venous Thrombosis Virtual Surveillance in COVID-19 (VVIRTUOSO)

Covid19 | Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

Canada
Centre Hospitalier Universitaire, Amiens

Completed

Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy (THROMBOCOVID)

COVID-19 | Pneumonia | ARDS | Hemostasis | Coagulation

France
University Hospital, Brest

Active, not recruiting

Cardiovascular and Venous Thromboembolism Disease in Patients With Von Willebrand Disease in the French West (TWIGO)

Von Willebrand Diseases

France
Daiichi Sankyo, Inc.

Completed

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Pulmonary Embolism | Venous Thromboembolism (VTE) | Deep Vein Thrombosis (DVT)

United States, Israel, Spain, Czechia, Singapore, Canada, Argentina, Brazil, Bulgaria, Chile, Croatia, Denmark, El Salvador, France, Germany, Guatemala, Hungary, India, Kenya, Korea, Republic of, Lebanon, Malaysia, Netherlands, Norway, ... and more
Johns Hopkins University
Patient-Centered Outcomes Research Institute

Completed

Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis (ENACT)

Venous Thrombosis (Disorder)

United States
Ottawa Hospital Research Institute
The Ottawa Hospital Academic Medical Association

Withdrawn

Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients

Cancer | Venous Thromboembolism | Pulmonary Embolism | Deep-Vein Thrombosis

Canada
Arianna Anticoagulazione Foundation

Terminated

Apixaban for Extended Anticoagulation (APIDULCIS) (APIDULCIS)

Venous Thromboembolism | Anticoagulants

Italy
Boston Scientific Corporation
BTG International Inc.

Completed

An International Pulmonary Embolism Registry Using EKOS (KNOCOUT PE)

Pulmonary Embolism and Thrombosis

United States, United Kingdom, Switzerland, Austria, France, Germany, Netherlands, Turkey
Cipherome, Inc.
Santa Clara Valley Medical Center

Completed

Association Between Genetic Variant Scores and Warfarin Effect (AWARE1)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism | Intracardiac Thrombus | Venous Thromboembolic Disease

United States
Cardioangiologisches Centrum Bethanien

Completed

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

Venous Thromboembolism | Antiphospholipid Syndrome | Major Bleed | Arterial Thromboembolism

Germany
Military Institute of Medicine, Poland

Terminated

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome. (ENOX-inNS)

Nephrotic Syndrome

Poland
Association des Médecins Vasculaires Hospitaliers
Sanofi; Ministry of Health, France; Daiichi Sankyo, Inc.; LEO Pharma; University...

Completed

Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT ) (SPOT)

Cardiovascular Diseases | Venous Thromboembolism | Post Thrombotic Syndrome

France

Search clinical trials for: Unsuspected Venous Thromboembolism

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations